Research Highlights: Backtracking on CYP2C19 genotyping in clopidogrel therapy?

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)791
Number of pages1
JournalBiomarkers in Medicine
Volume4
Issue number6
DOIs
StatePublished - Dec 2010

Fingerprint

clopidogrel
Research
Therapeutics
Cytochrome P-450 CYP2C19

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Drug Discovery

Cite this

Research Highlights : Backtracking on CYP2C19 genotyping in clopidogrel therapy? / Park, Jason.

In: Biomarkers in Medicine, Vol. 4, No. 6, 12.2010, p. 791.

Research output: Contribution to journalArticle

@article{154ce4765cc14520a8b6d67ba943e561,
title = "Research Highlights: Backtracking on CYP2C19 genotyping in clopidogrel therapy?",
author = "Jason Park",
year = "2010",
month = "12",
doi = "10.2217/bmm.10.99",
language = "English (US)",
volume = "4",
pages = "791",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Research Highlights

T2 - Backtracking on CYP2C19 genotyping in clopidogrel therapy?

AU - Park, Jason

PY - 2010/12

Y1 - 2010/12

UR - http://www.scopus.com/inward/record.url?scp=78650746020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650746020&partnerID=8YFLogxK

U2 - 10.2217/bmm.10.99

DO - 10.2217/bmm.10.99

M3 - Article

C2 - 21133697

AN - SCOPUS:78650746020

VL - 4

SP - 791

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 6

ER -